New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Xenadrine Reaction on Baseball Player's Death

MANASQUAN, N.J., Feb. 18 /PRNewswire/ -- The Broward County, Florida Medical Examiner reports that former Baltimore Orioles pitcher Steve Bechler was taking three capsules every morning of the ephedra-based diet supplement Xenadrine RFA-1, according to statements from family members and teammates. The medical examiner says he is investigating a possible link between Bechler's use of Xenadrine RFA-1 and his death. The recommended dosage, according to the product's label is "two capsules twice a day."

Physicians warn that many adverse events related to ephedra are due to people taking more than the recommended dosages, presumably in hopes of accelerating weight-loss.

"Some of the problems we've seen from Ephedra could have come from people who are taking more of the recommended dose. It's important to follow the directions, and take the dose recommended on the bottle. Taking more can cause serious problems," said Dr. Diane Krieger of Miami Research Associates and South Miami Hospital, FL.

Dr. Krieger has conducted several clinical studies into the safety and efficay of Xenadrine RFA-1.

Cytodyne Technologies of Manasquan, NJ, maker of Xenadrine RFA-1 has issued the following statement.

"Due to the lack of medical evidence available at this time, Cytodyne is unable to specifically comment on the circumstances surrounding the tragic death of Steve Bechler. Until the toxicology report becomes available the cause of death remains unknown and may never be known. What is clear is that Xenadrine has been the subject of numerous clinical trials on people, which have conclusively demonstrated that the product is safe and effective when used as directed."

Xenadrine RFA-1 is the most-popular ephedra-based diet pill in America sold at Wal-Mart, GNC and thousands of other stores across the nation.

In a clinical study recently published in the International Journal of Obesity, Dr Krieger reported that Xenadrine RFA-1 patients' heart rates and other vital cardiac functions were no different than those of patients taking a placebo.

"There have been a lot of safety concerns about Ephedra. And we were looking to add to the body of knowledge about the safety, looking at it in an objective way. And our findings were that in a short period of time, taken by healthy overweight volunteers, there were no safety concerns, said Dr. Kreiger." "We asked healthy overweight volunteers to take either Xenadrine or a sugar pill. And over a two week period, we measured their heart rates, blood pressures, electrocardiogram and eco-cardiograms. Our findings were that there were no differences between the Xenadrine group and the placebo group, or the sugar pill group, with respect to heart function. Specifically blood pressure, heart rate, electro-cardiograms and echo-cardiograms over two weeks," said Dr. Kreiger.

Xenadrine says ephedra-based diet pills are not for everyone, especially children, people with histories of heart conditions, pregnant and nursing mothers, people with thyroid and other disorders. For the vast majority of people who are healthy but overweight, Xenadrine RFA-1 has proven to be safe and effective, when used as directed. Millions of people report loosing tons of weight taking Xenadrine RFA-1, without side effects.

CONTACT: Evan Horisk of World Satellite Television News, +1-212-683-4242, for Cytodyne Technologies

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.